The U.S. Food and Drug Administration has approved the antiretroviral drug Truvada, to be used as a preexposure preventive measure by people who, uninfected, may be exposed to the virus through HIV-positive partners. The drug previously was approved to treat people living with HIV. As a preventive measure the drug would be taken daily, by […]
Justice in Prisons: Health Access, Treatment and Prevention at Prisoner Networking Zone Often coming from situations of the greatest risks for HIV, the dangers confronting prisoners are multiplied when, in overcrowded cells, lacking basic nutrition, health and hygiene and ability to protect themselves from infection, they are locked away, whether convicted or awaiting trial in […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster The following […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]